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Background: Caregiving for dementia has been associated with increased grief and burden. 
Dementia with Lewy Bodies (DLB) is the second most common form of dementia; yet, extant 
studies have focused primarily on caregivers of people with Alzheimer’s disease (AD). By result, 
the current state of the literature overlooks potentially important differences between caregivers 
of DLB and other dementia types. Caregivers of DLB face unique challenges early in their 
caregiving role; thus, it is likely that they experience grief and burden at earlier stages than other 
dementia types. The purpose of the present study was to examine the differences in the 
experience of grief and burden in caregivers of DLB versus caregivers of AD and Parkinson’s 
Disease with Dementia (PDD) at different disease stages.  
Method: Family caregivers of individuals with DLB (n = 415), AD (n = 71), or PDD (n = 66) 
completed a series of self-report online surveys. 
Results: Caregivers of DLB reported significantly more grief at earlier stages in the disease 
course than caregivers of AD. No significant differences in grief were found between caregivers 
of DLB and PDD. Caregivers for people with DLB, AD, and PDD had very similar profiles for 
burden. 
Implications: These findings support the hypothesis that there are differences in the experience 
of caregiving for those with DLB and other dementia types. More research is needed to 
investigate other potential differences in the caregiving experience for patients with DLB.   
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Chapter 1: Relevant background  
With current medical advances, the number of people age 65 years and older living in the 
United States (U.S.) is expected to grow by 13% from 2010 to 2030, and make up approximately 
20% of the total population (Vincent & Velkoff, 2010). As the number of older Americans 
grows, so too will the numbers of new and existing cases of dementia that will require caregiver 
assistance (Hebert, Weuve, Scherr, & Evans, 2013). The financial and emotional burden of 
caregiving for those with dementia is high (Alzheimer’s Association, 2016). According to the 
Alzheimer’s Association (2016), in 2015, 15.9 million caregivers provided an estimated 18.1 
billion hours of unpaid care—valued at more than 221.3 billion dollars.  The estimated cost of 
healthcare, long-term care and hospice for dementia patients in 2015 was 236 billion dollars 
(Alzheimer’s Association, 2016). Caregivers also shoulder a lot of physical and emotional 
burden that lead to health care costs of their own; 59% of family caregivers of dementia patients 
rated the emotional stress of caregiving as high or very high (Alzheimer’s Association, 2016). 
Caregiving for dementia has been associated with a decreased sense of well-being, depression, 
anger, anxiety, guilt, and other caregiver health and medical problems (Brodaty, & Donkin, 
2009; Etters, Goodall, & Harrison, 2008; Pinquart & Sörensen, 2003). 
There are several types of dementia—each with a different clinical presentation. Unique 
onset and disease course among dementia types likely affect caregivers differently. Yet, there are 
relatively few studies that examine potential differences among caregivers. Extant studies have 
focused primarily on caregivers of patients with Dementia of the Alzheimer’s type (AD) and 
there are relatively few studies that examine the experience of caregivers of Dementia with Lewy 
Bodies (DLB) or Parkinson's Disease with Dementia (PDD). By result, the current state of the 




This paper will focus on DLB as compared to AD and PDD. All three of these diseases share 
some overlapping symptoms. However, they have different underlying disease processes and 
different clinical presentations—AD is marked by memory loss, DLB has prominent psychiatric 
features and fluctuation cognition, and PDD presents with marked motor impairment. Each is 
described in greater detail below. 
Dementia of the Alzheimer’s type (AD) 
Clinical symptoms of AD manifest concurrent with the aggregation of proteins in the 
brain—commonly referred to as plaques and tangles (Alzheimer’s Association, 2016). The 
plaques are made of beta amyloid that builds up in the spaces between nerve cells and cause 
neural connection problems (Alzheimer’s Association, 2016; Jack et al., 2011; National Institute 
of Neurological Disorders and Stroke (NINDS), 2015). The tangles are made of another protein 
called tau that builds up inside neurons and causes eventual cell death (Alzheimer’s Association, 
2016; Jack et al., 2011; NINDS, 2014).  
AD is the most common form of dementia in the U.S.—affecting an estimated 5.2 million 
people in the U.S. (Alzheimer’s Association, 2016). According to the Alzheimer’s Association 
(2016), AD is typically diagnosed after age 65 and is more common in women—this is likely 
due to the fact that women tend to live longer than men. The average survival time following a 
diagnosis is 8 years. The most prominent feature of AD is memory loss. This loss is usually 
persistent and gradual; AD typically effects short-term memory first and then long-term memory. 
The early indicators of AD tend to be memory and thinking problems, while psychiatric 
problems tend to occur at later stages in the disease process (Alzheimer’s Association, 2016; 




The diagnostic criteria for probable AD (Alzheimer’s Association, 2016; Jack et al., 
2011) include deficits in two or more areas of cognition: (a) progressive worsening of memory, 
and (b) progressive worsening of other cognitive functions. The diagnosis of probable AD is 
supported by: (a) progressive deterioration of specific cognitive functions such as language 
(aphasia), motor skills (apraxia), and perception (agnosia); (b) impaired activities of daily living 
and altered patterns of behavior; (c) family history of similar disorders, particularly if confirmed; 
(d) biomarkers showing an elevation in a-beta amyloid and tau; and (e) exclusion of other non-
AD causes of dementia. 
Lewy Body Disease (LBD) 
The pathological hallmark of PD, PDD and DLB is the aggregation of Lewy bodies 
(LBs) in the brain. LBs consist of abnormal neuronal accumulation of a protein called α –
synuclein (Alzheimer’s Association, 2016; Lewy Body Dementia Association, 2015; McKeith, 
2004; Meeus, Theuns &Van Broeckhoven, 2012; National Parkinson Foundation, 2015; Neef & 
Walling, 2006; NINDS, 2014). Amyloid plaques seen most commonly in AD may also be 
present in some cases of DLB, but 80-90% of DLB cases do not feature the tau protein 
neurofibrillary tangles that are typical of AD (McKeith, Burn, O’Brien, Perry, & Perry, 2002). 
While AD pathology and/or vascular changes may also be present in PD, PDD and DLB, it is not 
necessary for symptoms of dementia to occur (McKeith et al., 2005; NINDS, 2014).   
While both PD and DLB share underlying pathology, the onset of PD is marked by motor 
impairment whereas the onset of DLB is marked by cognitive impairment and psychiatric 
problems (Alzheimer’s Association, 2016). If cognitive symptoms appear within a year of 
movement problems, a diagnosis of DLB is typically made. If cognitive problems develop more 




Association, 2015; McKeith et al., 2005; NINDS, 2014). Ballard, Kahn, & Corbett (2011) made 
the argument that DLB and PDD are essentially the same disease, but with differences in the 
presentation and disease course. This view is debated in the literature. The current “one year” 
rule may seem arbitrary, but it is currently the most accurate way to group DLB and PDD 
patients according to symptomology and disease progression. 
Parkinson's disease with dementia (PDD) 
An estimated 1 million people are affected with Parkinson’s disease (PD; National 
Parkinson Foundation, 2015). A prior diagnosis of PD is necessary to obtain a diagnosis of PDD, 
but not all PD patients will transition to PDD. However, the rate of transition is high—with 50 to 
80% of PD patients eventually being diagnosed with a form of dementia (National Parkinson 
Foundation, 2015). PD is usually diagnosed after age 60, and men are 50% more likely than 
women to develop it (NINDS, 2014; National Parkinson Foundation, 2015). In a recent large-
scale study, the median survival time in PD from motor onset was 15.8 years (Forsaa, Larsen, 
Wentzel-Larsen, & Alves, 2010). Another study found that within 6 years of their PD diagnosis 
71% of women and 67.5% of men were diagnosed with dementia; it was also found that having 
PD complicated by dementia was associated with a greater likelihood of death than having PD 
alone (Willis, Schootman, Kung, Bradley, Perlmutter, & Racette, 2012). In PD, movement 
problems are the primary symptom present at disease onset; memory and thinking problems, as 
well as psychiatric problems can appear or increase if a patient transitions to PDD (Forsaa et al., 
2010; Lewy Body Dementia Association, 2015). 
The diagnostic criteria for PDD, according to the Diagnostic and statistical manual of 
mental disorders (DSM-5; 5th ed., 2013), includes (a) evidence of significant cognitive decline 




executive function, learning, memory, language, perceptual-motor or social cognition); (b) the 
cognitive deficits interfere with independence in everyday activities; (c) the cognitive deficits 
don’t occur exclusively in context of a delirium, and are not better explained by another mental 
disorder; (d) the disturbance occurs in the setting of established PD; and (e) there is insidious 
onset and gradual progression of impairment. Associated clinical features of PD include: (a) 
cognitive features with impaired: attention, executive function, visuospatial function, memory; 
and language; and (b) behavioral features: apathy, changes in personality and mood (including 
depressive features and anxiety), hallucinations, delusions, and excessive daytime sleepiness. 
Dementia with Lewy Bodies (DLB) 
DLB is estimated to affect 1.3 million people in the United States (Lewy Body Dementia 
Association, 2015). DLB is the second most common form of dementia (Galvin et al., 2010a; 
Leggett, Zarit, Taylor, & Galvin, 2010; McKeith, 2004; Meeus et al., 2012). In DLB, the disease 
onset is typically between ages 50-83 and there is a slight male predominance (Lejbak & 
Haugrud, 2010). The average survival following a diagnosis is 5 to 7 years and the median age of 
death for a person with DLB is 78 (Lewy Body Dementia Association, 2015; Galvin et al., 2008; 
Williams, Xiong, Morris, & Galvin, 2006). DLB is also associated with a shorter time to 
institutional placement than AD (Tarawneh & Galvin, 2007).  
Consensus diagnostic criteria for DLB (McKeith et al., 2005) include the presence of 
progressive cognitive decline that is severe enough to interfere with daily life in conjunction with 
at least two of the following three core features: (a) fluctuating cognition with pronounced 
variations in attention and alertness, (b) recurrent visual hallucinations, or (c) spontaneous motor 




severe neuroleptic sensitivity, hallucinations, rapid eye movement (REM) sleep behavior 
disorder (RBD), and depression.  
Features of Dementia with Lewy Bodies 
DLB has many symptoms in common with psychiatric disorders and other dementia types 
(American Psychiatric Association, 2013); thus, DLB is frequently misdiagnosed as a psychiatric 
disorder or another type of dementia (Leggett et al., 2010; Tarawneh & Galvin, 2007). While 
DLB has many symptoms in common with other psychiatric disorders and dementia types, the 
onset and disease course of DLB is unique (Lewy Body Dementia Association, 2015; McKeith, 
2004). Unique features of DLB include the early onset of recurrent visual hallucinations, RBD, 
and spontaneous alterations in concentration and attention (or fluctuating cognition; Lewy Body 
Dementia Association, 2015; McKeith, 2004; Tarawneh & Galvin, 2007). Moreover, these 
symptoms are often present when the care recipient receives a diagnosis of probable DLB, as 
opposed to AD where these problems usually do not appear until the latter stages in the disease 
process (Alzheimer’s Association, 2016; Lewy Body Dementia Association, 2015; McKeith, 
2004; National Parkinson Foundation, 2015).  
Difficulty diagnosing Dementia with Lewy Bodies. Caregivers of DLB report difficulty 
obtaining a correct diagnosis (Galvin et al., 2010a). As a result, DLB is likely underreported 
(McKeith, 2004). One of the reasons for the misdiagnosis of DLB is that it is a relatively new 
disease classification and is not nearly as common as AD or as easy to identify  as PDD (due to 
motor impairment in PDD; Alzheimer’s Association, 2016; Lewy Body Dementia Association, 
2015). It also shares many features with AD, PD, and PDD (Galvin et el., 2010a; Johnson, 
Morris & Galvin, 2005; McKeith et al., 2002). Another reason for the difficulty in obtaining a 




the disease process, and doctors often mistake these symptoms for a psychiatric disorder rather 
than DLB (Galvin et al., 2010a; Johnson et al., 2005; McKeith et al., 2002). Additionally, some 
key diagnostic symptoms may go unreported by the caregiver, because they may seem unrelated 
to what people think of as dementia (e.g., fluctuating cognition, delusions; Lewy Body Dementia 
Association, 2015). Thus, getting a probable DLB diagnosis can take several visits to different 
physicians, which can be frustrating, costly, and time consuming (Galvin et al., 2010a). 
Unfortunately, a delay in obtaining an accurate diagnosis can lead to the inappropriate 
administration of traditional neuroleptics for psychiatric symptoms; the use of neuroleptics can 
result in an increase in psychotic symptoms and death in DLB and PDD (Emre et al., 2007; 
McKeith et al., 2002; Neef & Walling, 2006).  
REM sleep behavior disorder (RBD). RBD is a sleep disorder where the individual moves 
during their REM sleep cycle. RBD often appears months or years before there are any 
symptoms of dementia, which makes it a useful tool for identifying those at greater risk of 
conversion to a neurodegenerative disease (Donaghy, O'Brien, & Thomas, 2015; Lewy Body 
Dementia Association, 2015; McKeith, 2004). A recent longitudinal study found that the risk of 
developing a neurodegenerative disease from the time of idiopathic RBD diagnosis was 33.1% at 
five years, 75.7% at ten years, and 90.9% at 14 years (Iranzo et al., 2014). The risk of converting 
to DLB, PD, or PDD after being diagnosed with RBD is relatively high, and RBD has been 
found to be more common in DLB and PDD than in other types of dementia (Boeve et al., 2013; 
Chiba et al., 2012; Iranzo et al., 2014; Munhoz, & Teive, 2014; Murray et al., 2013; Nagahama  
et al., 2007; Postuma et al., 2015; Suárez-González et al., 2014; Thaipisuttikul, Lobach, Zweig, 




RBD is one of the supportive features in the diagnostic criteria of DLB. RBD differs from 
night terrors in that RBD occurs during REM sleep (while our bodies are normally paralyzed) 
and is associated with LB pathology, whereas night terrors tend to occur during periods of deep 
sleep (i.e., the first third of nocturnal sleep) and can happen in healthy individuals (American 
Psychiatric Association, 2013; WHO, 1992). RBD can result in kicking, spitting, swearing, and 
hitting of nearby people while the affected acts out their dream (McKeith, 2004). This sleep 
disorder can prove dangerous for the individual and caregivers, especially spouses sleeping in the 
same bed with the care recipient (Lewy Body Dementia Association, 2015). It is also 
emotionally taxing, as the experiences can be frightening for both the individual and their 
caregivers (Boeve, Silber, & Ferman, 2004).  
Fluctuating Cognition. Fluctuating cognition is a cardinal feature of DLB with a frequency 
of 80-90% (McKeith, 2004, McKeith et al, 1996).  Bonanni et al. (2008) found that few PDD 
patients presented with the symptom of fluctuating cognition at disease onset. Those with a 
diagnosis of AD report periodic fluctuations in memory problems that are distinguishable from 
the fluctuations seen in DLB (Bradshaw, Saling, Hopwood, Anderson, & Brodtmann, 2004). 
Fluctuating cognition includes the following features: daytime drowsiness and lethargy, daytime 
sleep of two or more hours, staring into space for long periods, and episodes of disorganized 
speech (Lewy Body Dementia Association, 2015). Caregivers describe these fluctuations as 
having a spontaneous, periodic, transient quality that appear to interrupt the ongoing flow of 
awareness or attention (Bradshaw et al., 2004). This symptom can be distressing to caregivers, 
because of the unpredictability of the episodes. The individual with DLB can be lucid at one 
moment and then confused or non-responsive the next. This makes planning events and other 




supervision for some activities, as the DLB the care recipient’s alertness may change over the 
course of minutes, hours, or days (McKeith, 2004). 
Psychiatric features in Dementia with Lewy Bodies  
Psychiatric symptoms in DLB tend to occur at disease onset and remain stable across the 
disease course (McKeith et al., 2005; Tarawneh & Galvin, 2007). Comorbid psychiatric 
symptoms are a defining feature of DLB, and set DLB apart from the other dementia types. 
Patients often present with psychiatric problems like hallucinations, delusions, depression, and 
paranoia at disease onset (Alzheimer’s Association, 2016; Galvin et al., 2010b; Lewy Body 
Dementia Association, 2015; McKeith, 2004; McKeith et al., 2005).  
When individuals with DLB experience hallucinations and delusions it can be very 
distressing for their caregivers, because of the tangible change in their loved one’s behavior and 
the unpredictable and unexpected nature of the changes. Patients can even become violent or 
difficult for the caregiver to manage. Another challenging aspect of caregiving for people with 
DLB is the personally changes that are seen from disease onset and through the progression of 
the disease. For instance, the DLB the care recipient may demonstrate diminished emotional 
responsiveness, resign hobbies, progressive apathy, and purposeless hyperactivity (Galvin, 
Malcom, Johnson, & Morris, 2007; Leggett et al., 2010). Each of the psychiatric comorbidities in 
DLB is discussed below in further detail.  
Visual hallucinations (VH). Hallucinations and misperceptions are common in DLB. 
Their occurrence is associated with LB pathology in the amygdala, parahippocampus and 
inferior temporal lobe, and may involve disrupted cortical connections between the occipital and 
temporal lobes (Harding et al., 2002). According to the Lewy Body Dementia Association 




common. VH are a core diagnostic feature of DLB and are the most common psychiatric feature 
in DLB (McKeith, 2004; Nagahama et al., 2007; Onofrj et al. 2013; Thaipisuttikul et al., 2013). 
VH have also been shown to be more common in DLB than in any other types of dementia and it 
is often argued that this symptom is the most effective at differentiating DLB from other 
dementia types (Auning et al., 2011; Bjoerke-Bertheussen, Ehrt, Rongve, Ballard, & Aarsland, 
2012; Delli Pizzi et al., 2014; Erskine et al., 2015; Fujishiro et al. 2008; Yokoi, et al., 2014). 
Tiraboschi et al. reported an 83% positive predictive value of VH in distinguishing DLB from 
AD. VH in DLB can be simple (seeing objects move when they are actually still) or complex 
(seeing people and items that are not present; Teeple, Caplan, & Stern, 2009). Patients may or 
may not have insight into their hallucinatory content (Teeple et al., 2009).  
Treating VH in DLB has proven difficult. DLB and PDD patients have an antipsychotic 
sensitivity to neuroleptics (McKeith et al., 2002; Neef & Walling, 2006). Unfortunately, the 
administration of traditional neuroleptics for psychiatric symptoms is common, and if 
administered to those with DLB or PDD, can result in an increase in psychotic symptoms and 
death (McKeith et al., 2002; Neef & Walling, 2006). If the VH are left untreated, symptoms 
persist and can markedly impair quality of life of the patient (Boström et al., 2007a; McKeith et 
al., 2002; Neef & Walling, 2006), and significantly increase caregiver distress (Ricci et al., 
2009). Cholinesterase inhibitors are the preferred treatment for DLB, and can improve cognitive 
function and reduce psychotic symptoms (Galvin et al., 2008; McKeith et al., 2002). However, 
this treatment often exacerbates parkinsonian symptoms. Because of the difficulties in treating 
DLB, McKeith, Burn, O’Brien, Perry, & Perry (2002) liken the management of symptoms to 
walking a tightrope with the outcome “a compromise between a relatively mobile but psychotic 




Delusions and misidentifications. Delusions are common in DLB at all stages of the 
disease (McKeith, 2004). While AD and PDD patients also experience delusions, these 
symptoms usually do not appear until the later stages of AD and PDD (Alzheimer’s Association, 
2016; National Parkinson Foundation, 2015). Thus, delusions are more common at early stages 
of DLB than in other dementia types (Bjoerke-Bertheussen et al., 2012; Boström, Jönsson, 
Minthon, & Londos, 2007b; Kao et al. 2009; Suárez-González et al., 2014; Thaipisuttikul et al., 
2013). Delusions often present as paranoid delusions or delusional misidentifications (Suárez-
González et al., 2014). There is some debate in the literature whether misidentifications are 
delusions or hallucinations. According to a factor analysis done by Nagahama, et al. (2007), 
misidentifications loaded onto a factor separate from visual hallucinations. For the purpose of 
this paper, they will fall under the category of delusions.  
Misidentifications can occur in neurodegenerative diseases, psychiatric disorders and 
brain injuries (e.g., stroke, traumatic brain injury; Harciarek, & Kertesz, 2008). A recent study 
found that misidentifications were identified in 16.6% of DLB cases, 15.8% of AD cases, and 
0.0% of PD cases in their sample (Harciarek, & Kertesz, 2008). There are several types of 
misidentifications, but the most common in DLB is Capgras syndrome (Harciarek, & Kertesz, 
2008). This is the delusion that an identical-looking impostor has replaced a spouse, friend, 
parent, or other close family member. This delusion is particularly troubling for caregivers, as 
they are often the object of the delusion (Thaipisuttikul et al., 2013) and patients can become 
resistant to care, violent, abusive and difficult to control when they believe that the caregiver is 
not who they say they are (De Pauw & Szulecka, 1988; Silva, Leong, Weinstock, 1992; Silva, 
Leong, Weinstock & Boyer, 1989). Unsurprisingly, the presence of Capgras has been shown to 




(Thaipisuttikul et al., 2013). Delusions and misidentifications can occur at any point in the 
disease course for DLB patients (McKeith, 2004). They can also occur in AD and PDD, but 
typically not until later stages of the disease course (Alzheimer’s Association, 2016; National 
Parkinson Foundation, 2015). 
Depression. The Lewy Body Dementia Association (2015), reported that 37% of DLB 
cases present with depression. Epidemiological studies have found that depression is the most 
commonly diagnosed illness prior to the diagnosis of DLB (Boot et al., 2013; Fereshtehnejad et 
al., 2014). Additionally, depression has been found to be more common in DLB at all stages of 
the disease than in other types of dementia (Auning et al., 2011; Bjoerke-Bertheussen et al., 
2012; Boot et al., 2013; Chiba et al., 2012; Fujishiro et al. 2008; Sadak, Katon, Beck, Cochrane, 
& Borson, 2014; Thaipisuttikul et al., 2013; Yamane, Sakai, & Maeda, 2011).  
Caregiving in dementia 
With the progression of dementia, caregivers are increasingly responsible for providing 
assistance with activities of daily living (ADL) and instrumental activities of daily living (IADL; 
Alzheimer’s Association, 2016; Lewy Body Dementia Association, 2015; National Parkinson 
Foundation, 2015; Tarawneh & Galvin, 2007). In DLB, PDD and AD caregiving typically 
includes assistance or oversight with self-care tasks and ADLs: bathing, dressing, grooming, 
feeding, and assisting with toilet use or managing incontinence (Alzheimer’s Association, 2016; 
Lewy Body Dementia Association, 2015; National Parkinson Foundation, 2015). Caregivers of 
DLB, AD and PDD typically manage instrumental activities of daily living (IADL): shopping for 
groceries, preparing meals, managing finances, completing household chores, providing 




supervision to prevent wandering (Alzheimer’s Association, 2016; Lewy Body Dementia 
Association, 2015; National Parkinson Foundation, 2015).  
As the functional needs of the care recipient increase, the caregiver is more likely to use 
external resources or institutionalize the patient, which results in greater cost of care. Those with 
DLB commonly have a shorter time to institutional placement and mortality than those with AD 
(Tarawneh & Galvin, 2007). The cost of care for those with DLB was significantly greater when 
compared to those with AD (Boström et al., 2007b). Functional decline in DLB is more rapid 
than in AD (Tarawneh & Galvin, 2007; Williams et al., 2006). DLB patients are also more 
functionally impaired in ADLs than patients with AD, even when their cognitive test scores are 
similar (Boström et al., 2007b). This is generally due to their visuospatial deficits, fluctuating 
cognition, early and severe executive dysfunction, and extrapyramidal symptoms (Galvin et al., 
2010b; McKeith et al., 2006). In a recent study, the cost of care was shown to be significantly 
correlated with the dementia patient’s dependency in IDALs (Boström et al., 2007b).  
Caregiver grief. One painful aspect of being a caregiver of a dementia patient is the grief 
that goes along with watching your loved one functionally decline and eventually die. Grief 
results from perceived loss, and can manifest in psychological, physical, social, behavioral and 
affective forms (Ott, Reynolds, Matovina Schlidt & Noonan, 2006; Ott, Sanders, & Kelber, 
2007; Marwit and Meuser, 2002; Rando, 2000). Symptoms of grief include sadness, yearning, 
crying, changes in sleep and appetite, anger, frustration and trouble concentrating (Ott et al., 
2006; Ott et al., 2007). Behavioral and emotional problems exhibited by dementia patients is 
associated with higher rates of caregiver emotional distress along with poorer mental and 




that behavior problems were the strongest determinant of grief among caregivers—even more so 
than disease stage or time spent on caregiving duties.  
Ott, Sanders, & Kelber (2007) found that the amount of grief experienced by caregivers 
of dementia increased as the care recipient’s disease course progressed. Similarly, Meuser & 
Marwit (2001) found that spousal AD caregivers experienced a significant increase in grief as the 
disease progressed and decline increased. An increase in grief intensity was also observed in 
caregivers when the care recipients were placed in nursing homes, despite the perceived 
decreases in stress and burden (Meuser & Marwit, 2001). However, both of these studies used 
AD caregiver samples, and may not provide information that is consistent with the experience of 
caregiving for other types of dementia. Additionally, caregivers of DLB often face these 
challenges early in the caregiving role, for example 43% of patients present with hallucinations 
at disease onset, and 37% with depression (Lewy Body Dementia Association, 2015).  
Caregiver Burden. Behavioral and emotional problems exhibited by dementia patients are 
often considered to be among the most stressful aspects of caregiving; thus, they are viewed as 
main source of dementia caregiver burden in the literature (Leggett et al., 2010; Papastavrou, 
Kalokerinou, Papacostas, Tsangari, & Sourtzi, 2007; Schulz & Sherwood, 2008). The amount of 
behavioral and emotional problems exhibited by dementia patient is associated with the amount 
of self-reported burden (Holley & Mast, 2010; Leggett et al., 2010; Papastavrou, et al., 2007; 
Schulz & Sherwood, 2008). The unique dementia profiles of DLB, PDD, and AD may alter the 
caregiver experience of burden.  
DLB patients generally have more severe behavioral symptoms and more compromised 
functional abilities at disease onset when compared with AD (Ricci et al., 2009). The presence of 




and depression are prominent in DLB; the unpredictability of these symptoms add to caregiver 
stress (Leggett et al., 2010; Ferman et al., 2012; Ricci et al., 2009). Additionally, caregivers of 
DLB often face these challenges early in the caregiving role. Unlike in DLB, delusions, 
depression, and paranoia usually do not appear until the latter stages of AD (Alzheimer’s 
Association, 2016; National Parkinson Foundation, 2015). In a recent study comparing 
caregivers of DLB and AD patients in early disease stages, high distress (caused by delusion, 
hallucinations, anxiety and apathy) was only observed in DLB caregivers (Ricci etal., 2009). As 
AD progress the burden placed on the caregivers increase, whereas the burden placed on DLB 
caregivers is relatively high at the onset and remains relatively stable across the disease course.  
The present study 
Extant studies have focused primarily on caregivers of patients with AD. There are 
relatively few studies that examine the experience of caregivers of DLB. By result, the current 
state of the research overlooks potentially important differences between DLB and other 
dementia types. The purpose of the present study was to examine the differences in the 
experience of grief and burden in caregivers of DLB versus caregivers of AD and PDD. Since 
early onset of psychiatric symptoms and fluctuating cognition are defining features of DLB, it 
was anticipated that the caregivers of DLB would perceive more mental health and behavioral 
problems in their loved ones at earlier stages in the disease course than caregivers of individuals 
with AD or PDD. Because the amount of behavior and emotional problems exhibited by the 
patient is associated with higher rates of caregiver distress and grief (and DLB patients often 
exhibit psychiatric symptoms at disease onset), it was anticipated that caregivers of DLB would 
experience grief at earlier stages than caregivers of AD or PDD. Finally, it was predicted that the 




the disease course than for caregivers of either AD or PDD, due to the high rates of psychiatric 






















Chapter 2: Method 
Participants 
 Potential participants were initially contacted with the assistance of the Lewy Body 
Dementia Association and sever partner organizations. Recruitment information was sent out to 
individuals on caregiver emailing lists of these organizations. The email provided potential 
participants with a link to the online study along with instructions on how to participate. There 
was no financial incentive for participation and participants provided their consent to participate 
prior to completing the survey. The participants who were selected for this study were either a 
spouse or an adult child caregiver of living individuals with a diagnosis of DLB, AD, or PDD.  
Several chi-square tests of independence were performed—comparing disease types on 
caregiver and patient demographic characteristics. The following caregiver demographics did not 
yield a significant chi-square: sex, education and patient’s disease stage. The chi-square 
comparing disease types on caregiver race was significant, 2 (10, N = 546) = 19.92, p = .03. 
This result was likely due to the fact that the majority of the sample identified as white and the 
cell counts for many of the other race types were small or zero. However, when race categories 
were collapsed into white and non-white categories, the chi-square was no longer 
significant, 2 (2, N = 546) = 3.34, p = .19. Because caregiver race was not influencing the 
variables of interest, it was decided not to use caregiver race as a covariate. The chi-square 
comparing disease types on the caregiver’s relationship to patient was significant, 2 (6, N = 
552) = 13.18, p = .04. To reduce group differences, the caregiver’s relationship to patient was 
used as a covariate in the analyses. 
The following patient demographic characteristics did not yield a significant chi-square: 




of the patient was significant, 2 (2, N = 548) = 34.86, p = .001. To reduce group differences, sex 
of the patient was used as a covariate in the analyses. 
Disease type by caregiver age and patient age was also examined for differences using 
ANOVAs. Caregiver age was not found to be significantly different among the disease types. 
Patient age was found to be significantly different among the disease types (F(1,482) = 
12.58, p = .001). To reduce group differences, the patient age was used as a covariate in the 
analyses.   
Since there were comparatively few respondents who were caregiving for a patient with a 
perceived disease stage of “Mild” (n=40), the perceived disease stage of “Mild” and the disease 
stage of “Moderate” (n=312) were collapsed into one category (n=352). This new category 
represents earlier perceived disease stages and was compared to the unchanged category 
representing the later perceived disease stage, “Severe” (n=200). The demographic frequencies 
by disease type of the new categories (earlier disease stages & later disease stage) can be found 
in Table 1. 
Procedures 
  This survey was created and placed online using Survey Monkey 
(www.surveymonkey.com, Palo Alto CA). Eligible participants accessed the survey via an 
emailed link. The survey contained a total of 230 questions. Data was collected over a period of 
12 months. There was no completion time limit on the survey, and participants could save and 
return to the survey at a later date. Upon completion of the survey, contact information was 
provided to the participants in the case of their requiring further assistance. All personal 




approved by Internal Review Board at the New York University’s Medical Center to ensure the 
ethical use of archived data.  
Measures 
   Socio-demographic. A total of 13 questions assessed caregiver (respondent) 
demographic characteristics and features of care. A further 14 questions assessed demographic 
characteristics of the care recipient. 
Disease stage severity. Caregivers were asked to estimate the care recipient’s disease 
stage by responding to the following question: “To the best of your knowledge, what stage of 
disease would you say the patient is in? 1) Mild; 2) Moderate; 3) Severe; 4) Deceased.” 
Caregivers whose care recipient was deceased at the time of their participation in this study were 
not included in the analyses.   
  The care recipient behavior problems—Revised Memory and Behavior Problems 
Checklist (RMBPC). The RMBPC was used to assess the dementia care recipient’s overall level 
of behavioral problems and the degree of behavioral dysfunction—including memory-related 
problems, depression, and disruptive behaviors (see Appendix A.; Teri et al., 1992). It also 
provides indexes of the caregiver’s feelings of distress in response to the care recipient’s 
behavior problems (Teri et al., 1992). However, since the Zarit Burden Interview (see below) 
was selected as the measure of burden for this study, these indexes were not looked at as they are 
redundant.  According to Teri et al. (1992) the RMBPC has three first-order factors: Memory-
Related Problems, Depression, and Disruption. Reliabilities of the overall scales of the care 
recipients' behavior and caregiver reaction were very high (.84 and .90). The subscale reliabilities 
indexes ranged from moderately high to very high (.67 to .89). The RMBPC also has both good 




The RMBPC contains 24 statements, 1 total score and 3 subscale scores (memory-related, 
depression, and disruptive behaviors). Participants answer questions pertaining to the frequency 
of caregiver-observed behavioral problems in the patient. Questions are answered using a six-
point Likert scale ranging from 0 (never occurred) to 4 (Extremely), and 9 (don’t know/not 
applicable). Higher scores on the RMBPC referring to the care recipient’s behavior problems 
indicate greater levels of perceived behavior problems in the care recipient by the caregiver.  
Caregiver grief--Marwit-Meuser Caregiver Grief Inventory Short Form (MM-CGI-
SF). The MM-CGI-SF was created from the original full-length version of the Marwit–Meuser 
Caregiver Grief Inventory (MM-CGI; Marwit & Meuser, 2002). Both versions were designed to 
measure grief in caregivers of persons with progressive dementia (Marwit & Meuser, 2002; 
Marwit & Meuser, 2005). The MM-CGI-SF (see Appendix B.; Marwit, & Meuser, 2005) is 
composed of 18 statements and assesses caregiver grief on three factors: 1) Personal Sacrifice 
Burden; 2) Heartfelt Sadness and Longing; and 3) Worry and Felt Isolation. Participants 
responded using a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly 
agree).  Higher scores indicate greater feelings of grief. The three factors can be looked at 
individually or as a sum score of all items. 
The full-length version of the MM-CGI was developed using an exploratory factor 
analysis of 184 statements describing dementia caregiver grief and sadness (Marwit & Meuser, 
2002). Of the original 184 statements 50 were retained. The analysis revealed three factors with 
high internal consistencies. The first factor, Personal Sacrifice and Burden, was designed to 
measure what caregivers view as sacrifices they have had to make to be a caregiver (α = .93). 
The second factor, Heartfelt Sadness and Longing, is intended to represent the “true grief factor” 




noticeable signs in illness in the care recipient. The third factor, Worry and Felt Isolation, was 
deigned to capture caregivers’ uncertainty about the future and their feelings of being isolated 
from others. The sum score for all items was shown to have excellent internal consistency 
reliability (α = .96), and a split-half reliability of 0.91 (Marwit & Meuser, 2002). It was also 
shown to have a good test re-test reliability (Factor 1, r =.71; Factor 2, r = .73; Factor 3, r =.75; 
TG, r =.71; all ps < .01) and good convergent validity with measures covering similar content 
(Marwit & Meuser, 2002).  
The same three factors that were used in the full-length version of the measure were also 
used in the short-form (Personal Sacrifice Burden; Heartfelt Sadness and Longing; and Worry 
and Felt Isolation; Marwit & Meuser, 2005). The authors selected six items per factor that they 
regarded as being the most representative of that factor in terms of content and coverage (i.e., 
good face validity). The three factors on the short form were shown to be highly correlated with 
the same factors on the long form (Factor 1, r = .915; Factor 2, r = .925; Factor 3, r =.928; all ps 
< .01; Marwit & Meuser, 2005), indicating good concurrent validity.  Each of the three factors 
that comprise the 18-item MM-CGI-SF were also shown to have good internal consistency 
reliability (Factor 1, α = .83; Factor 2, α = .80; Factor 3, α =.80; Marwit & Meuser, 2005).  
Caregiver Burden—Zarit Burden Interview (ZBI). The level of perceived caregiver 
burden was assessed using a 12 item abridged version of the ZBI (see Appendix C.). The ZBI is 
one of the most commonly used measures of caregiver burden, and was originally developed for 
use with caregivers of AD.  The ZBI is comprised of questions asking caregivers about their 
experiences of emotional, physical, and social strains or difficulties that result from their role as 
a caregiver. Items include topics such as the degree to which their health has suffered due to 




and friends, and how much burden they feel from the caregiving role. In the ZBI, participants 
respond to questions using a five-point Likert scale ranging from 0 (never) to 4 (nearly always). 
Higher scores indicate higher perceived levels of burden. The version used in this study was 
taken from a recent paper that chose ZBI questions that were deemed more likely to target the 
concerns of caregivers of DLB (see Appendix C.; Leggett et al., 2010). A similar version of the 
ZBI was shown to have a high combined reliability (α = .86; Bédard, 2001). 
Data analysis 
Data analysis was performed using a SPSS statistical package version 23. Distributions 
were examined and outliers were looked for and addressed in the data. Two participants were 
removed from the analyses due to extreme scores. An additional sixteen were removed for lack 
of completion of the survey—beyond the demographics section. To reduce group differences the 
caregiver’s relationship to the patient, as well as the patient’s age and sex were used as 
covariates. Demographic information can be found in Table 1. Over all differences between the 
experience of caregiving for individuals with DLB versus caregiving for individuals with AD or 
PDD were explored using a series of ANCOVAs (see Table 2.).  Differences between the 
experience of caregiving for individuals with DLB versus caregiving for individuals with AD or 
PDD by stage (earlier stages vs. later stage) were also explored using a series of ANCOVAs (see 





Chapter 3: Results 
Caregiver reported patient behavioral problems. There were no significant overall 
differences on the RMBPC between dementia types and the caregiver perceived frequency of 
disruptive behavioral problems or the total frequency of behavioral problems (all ps > .05; see 
Table 2.). The overall reported frequency of depression (observed in the patient) on the RMBPC 
was significantly greater for those with DLB (M = 12.46, SD = 6.88) than for those with AD (M 
= 11.40, SD = 6.90; see Table 2.). The frequency of reported depression (observed in the patient) 
was significantly greater for those with DLB (M = 12.56, SD = 6.80) than for those with AD (M 
= 11.30, SD = 6.81) at earlier disease stages, while for the later stage there was no significant 
difference between the two diseases (see Table 3.). The overall reported frequency of memory 
related problems (observed in the patient) on the RMBPC was significantly greater for those with 
AD (M = 20.05, SD = 5.87) than for those with DLB (M = 17.48, SD = 6.78; see Table 2.). The 
frequency of reported memory problems (observed in the patient) was not significantly different 
between DLB and AD for earlier stages of the disease, while it was significantly greater for those 
with AD (M = 22.95, SD = 4.60) than for those with DLB (M = 17.80, SD = 7.77) at the later 
stage of the disease (see Table 3.).    
Those caring for individuals with DLB (M = 17.48, SD= 6.78) reported significantly 
greater overall frequency of memory problems (observed in the patient) on the RMBPC than 
caregivers of those with PDD (M = 15.43; SD = 6.57; see Table 2.). Caregivers for those with 
DLB (M = 17.33, SD= 6.25) reported significantly more memory problems than caregivers for 
those with PDD (M = 14.51; SD = 5.49) at the earlier stages of the disease course, while for the 




Reported Caregiver Grief. Caregivers of individuals with DLB (M = 22.46, SD = 4.93) 
reported significantly greater Heartfelt Sadness and Longing on the MM-CGI-SF overall than 
caregivers with AD (M = 20.71, SD = 5.58; see Table in 2.). Caregivers of individuals with DLB 
(M = 22.08, SD = 4.80) reported significantly greater Heartfelt Sadness and Longing than 
caregivers of AD (M= 19.37, SD = 5.26) at earlier stages of the disease course, while for the later 
stage there was no significant difference between the two diseases (see Table 3.). There were no 
other significant differences on the MM-CGI-SF between diseases (see Tables 2. & 3.). 
Reported Caregiver Burden. No significant differences between the dementia types 



















Chapter 4: Discussion 
Because of the early onset of psychiatric symptoms and fluctuating cognition associated 
with DLB, it was anticipated that the caregiver perceived frequency of patient overall behavioral 
problems and disruptive behavioral problems would be greater for caregivers of DLB at earlier 
stages in the disease course than for individuals with either AD or PDD; but, these dimensions 
were not significantly different between dementia types.  
As expected, the frequency of caregiver reported depression symptoms (seen in the 
patient) was significantly greater for those with DLB than for those with AD. Depression is a 
supportive feature for the diagnosis of DLB, and is common at all stages of the disease (Auning 
et al., 2011; McKeith et al., 2005). Conversely, psychiatric symptoms tend to be less common 
until the later stages of AD (Alzheimer’s Association, 2016). This lack of difference between 
DLB and AD at the later disease stage may be attributable to a caregiver perceived increase in 
depressive symptoms for those with AD, while the depression symptoms of those with DLB 
remain stable.  
There was no significant difference between those with DLB and those with PDD in 
caregiver reported depression symptoms (seen in the patient). The lack of difference between 
caregiver reported depression symptoms (seen in the patient) for DLB versus PDD is not 
surprising. Depression is part of the diagnostic criteria for both diseases, and is a common 
feature of both (Aarsland, Påhlhagen, Ballard, Ehrt, Svenningsson, & 2012; Auning et al., 2011; 
DSM-5, 5th ed., 2013; McKeith et al., 2005).   
As expected, the frequency of caregiver reported memory related problems (seen in the 
patient) was significantly greater for those with AD than for those with DLB; greater memory 




disease presentations of AD and DLB. Interestingly, the frequency of reported memory problems 
was not significantly different between DLB and AD at earlier stages of the disease. Memory 
deficits are a hallmark of AD at all stages of the disease (Alzheimer’s Association, 2016; 
American Psychiatric Association, 2013), whereas, noticeable memory impairment may not be 
easily differentiated at early stages of DLB (but is usually evident with the progression of the 
disease; McKeith et al., 2005). Deficits and variation in attention, alertness, and executive 
function are more prominent and typical at early stages of DLB (Lewy Body Dementia 
Association, 2015; McKeith et al., 2005). This lack of difference at earlier stages may be 
attributable to caregivers of DLB conflating the symptom of fluctuating cognition and/or general 
cognitive decline with memory problems. Consistent with the disease expected presentations for 
DLB and AD, the caregiver perceived frequency of memory related problems at the later stage of 
the disease course was significantly greater for those caring for loved ones with AD than for 
those caring for loved ones with DLB.  
Caregivers of those with DLB also reported significantly more (patient related) overall 
memory related problems than those with PDD. Caregivers for those with DLB also reported 
significantly more (patient related) memory problems than caregivers for those with PDD in the 
earlier stages of the disease course, though for the later stage there is no significant difference 
between the two diseases. While the common underlying pathology for DLB and PDD is the 
same (i.e., the aggregation of α –synuclein in the brain), they are still classified as different 
diseases because of differences in disease presentation and progression. To further complicate 
this picture, the amount of cortical LB pathology does not necessarily correlate with clinical 
dementia severity (Marui et al., 2002), and severe pathology can even be seen in the absence of 




The difference in memory problems found in this study may be attributable to differences in the 
localization, amount, and spread of LBs in addition to the comorbid aggregation of beta amyloid, 
neuronal atrophy, and/or vascular changes. Caregivers may also be conflating DLB patients’ 
problems with cognitive fluctuations and executive function deficits as memory problems.  
The overall reported Heartfelt Sadness and Longing was shown to be significantly greater 
for those caring for individuals with DLB than for those caring for individuals with AD. 
According to the creators of the MM-CGI, the factor Heartfelt Sadness and Longing is intended 
to represent the “true grief factor” of the loss of the relationship with the care recipient and a 
longing for how life was before the noticeable signs of illness in the care recipient (Marwit & 
Meuser, 2002). As anticipated, caregivers of individuals with DLB also reported significantly 
greater Heartfelt Sadness and Longing than caregivers for individuals with AD at earlier stages 
of the disease course, while for the later stage there is no significant difference between the two 
diseases. This finding supports the hypothesis that the early onset of psychiatric symptoms and 
fluctuating cognition associated with DLB leads to greater caregiver grief at early disease stages. 
This finding is also consistent with the caregiver literature indicating that the amount of behavior 
and emotional problems exhibited by the patient is associated with higher rates of caregiver 
distress and grief (Leggett et al., 2010; Schulz & Sherwood, 2008). The lack of difference 
between those with DLB and those with AD on the other two factors on the MM-CGI-SF 
(Personal Sacrifice and Burden & Worry and Felt Isolation) could be attributable to the overlap 
in difficulties that all caregivers face (e.g., making sacrifices to care for their loves one, worry 
about the future, feeling isolated from others).  
 Conversely, there were no significant differences between caregiver reported grief in 




recipients’ lack of mobility and decline in memory equating to the caregivers’ grief in DLB over 
psychiatric problems and fluctuation cognition. Another important thing to consider may be that 
by the time someone is diagnosed with PDD they are experiencing greater cognitive deficits and 
they may also exhibit some of the same psychiatric problems seen in DLB.    
Finally, it was anticipated that the reported subjective burden of caregiving for 
individuals with DLB would be greater at earlier stages in the disease course than for caregivers 
of either AD or PDD, because of the early onset of psychiatric symptoms and fluctuating 
cognition associated with DLB. However, little difference among caregivers was found. One 
caveat to this finding is that the measures used were developed primarily to assess the experience 
for AD caregivers; thus, they may not have adequately captured the unique facets of the DLB or 
the PDD caregiving experience. DLB caregivers face many unique demands and challenges that 
require the creation of new questionnaires that address the differences in the disease presentation 
and progression seen in DLB. Future studies addressing the caregiver experience between 
dementia types could make use of currently available tools that screen for symptoms that are 
more specific to DLB and less focused on memory deficits, which are not as common in DLB.  
The early onset of psychotic behavior is something that sets DLB apart from other 
dementia types (Auning et al., 2011; Suárez-González et al., 2014) and causes caregivers of DLB 
a great deal of distress (Ferman et al., 2012; Galvin et al., 2010b; Leggett et al., 2010). Current 
questionnaires for caregivers do a relatively good job at identifying memory, orientation, and 
problem solving deficits in the care recipient based on caregiver reports, but they lack more in-
depth questions about psychiatric problems. It would be beneficial to add questions that screen 
for this type of behavior into questionnaires assessing the caregiver experience. There are 




some of these symptoms. Also, the creation of more specific questionnaires could help to further 
identify differences between caregiving for DLB versus AD, and potentially identify any 
possible differences between the caregiving for DLB versus PDD.  
One common research tool that could be used is the Neuropsychiatric Inventory that 
screens for psychotic symptoms as well as other disturbances (Cummings et al., 1994). A recent 
study using a shortened form of this survey (NPI-Q) found that hallucinations and apathy 
occurred significantly more for those with DLB than those with other dementia types (Johnson, 
Watts, Chapin, Anderson, & Burns, 2011). Another study using the original full version of the 
NPI found that those with DLB had significantly more hallucinations, apathy, and a larger NPI 
summary score than those with AD (Boström etal., 2007b). Neither study was able to 
successfully differentiate DLB from other dementia types when comparing the incidence and 
severity of delusions; however, this may be due to the fact that these studies used participants at 
differing disease stages, and delusions have been shown to be more common at early stages of 
DLB than in other dementia types (Bjoerke-Bertheussen et al., 2012; Boström et al., 2007b; Kao 
et al. 2009; Suárez-González et al., 2014; Thaipisuttikul et al., 2013). Future studies could look 
at disease stage in conjunction with the psychiatric symptoms captured by the NPI.  
RBD is another symptom that can be very distressing for caregivers and the care 
recipients. There are currently several measures that screen for RBD and other sleep disorders. 
Among them are the RBD screening questionnaire (RBDSQ; Stiasny‐Kolster et al., 2007), 
RBDQ-HK (Li et al., 2010), and the Mayo Sleep Questionnaire (MSQ; Boeve et al., 2011). 
Because RBD is a supportive symptom in the DLB diagnostic criteria and has been shown to be 
more common in DLB than in other types of dementia (Chiba et al., 2012; Postuma et al., 2015; 




questionnaires for caregivers as they may further differentiate the caregiving experience of DLB 
from other types of dementia. 
Another prominent symptom of DLB that causes caregivers a lot of distress is fluctuating 
cognition. Since fluctuating cognition is a core feature of DLB, it might provide more insight 
into the difficulties of caring for an individual with these types of deficits if questions that 
capture these symptoms are included in questionnaires for caregivers. Unfortunately, studies 
show that fluctuations in cognition are difficult to define and capture consistently on assessments 
scales (Huang, & Halliday, 2013; Merdes et al., 2003; Verghese, Crystal, Dickson, & Lipton, 
1999). Still, there are currently several questionnaires that screen for fluctuating cognition (The 
Cognition Assessment of Fluctuation, One Day Fluctuation Assessment Scale, The Mayo 
Fluctuations Composite Scale). The Cognition Assessment of Fluctuation is designed to be 
administered by a clinician and evaluates fluctuating confusion over the month prior to the 
interview; unfortunately, this scale has poor inter-rater reliability and requires administration by 
a trained clinician (McKeith et al., 2005; Walker et al., 2000). The One Day Fluctuation 
Assessment Scale evaluates fluctuating confusion over the 24 hours prior to the assessment and 
can be administered by a variety of trained staff (McKeith et al., 2005; Walker et al., 2000). The 
Mayo Fluctuations Composite Scale includes screening questions of symptoms that occur more 
frequently in DLB than in AD (McKeith et al., 2005). A recent systematic review of cognitive 
fluctuation in dementia by Lee, Taylor, & Thomas (2012) suggests that these tools require 
further evaluation for their reliability and validity. Future studies could examine the ability of 
each of these tools to identify fluctuating cognition in care recipient populations and how 
effective they are at differentiating between dementia types, as well as how these types of 




One limitation of this study is that caregivers were asked to estimate the care recipient’s 
disease stage; thus, it is possible that they did not make accurate estimations. Additionally, the 
sample for this study exclusively contains individuals who were willing and able to participate 
using the internet; thus, the group may be younger, better educated, of a higher socioeconomic 
status, and more technologically savvy than those who did not participate. Also, respondents may 
not have felt comfortable providing answers that present themselves in an unfavorable manner. 
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Caregiver and patient demographic frequencies by disease
DLB AD PDD Total DLB AD PDD Total
n  = 415 n  = 71 n  = 66 n  = 552 n  = 415 n  = 71 n  = 66 n  = 552
Age (M (SD )) 61(11) 59(10) 63(10) 75(9) 79(9) 73(7)
Sex
Male 45 8 3 56 275 27 56 358
Female 386 62 63 493 138 43 9 190
Race
White 400 64 36 527 396 66 65 527
Black or African American 5 2 1 8 8 2 1 11
Asian 4 0 0 4 5 0 0 5
Native Hawaiian or other Pacific Islander 2 0 0 2 1 0 0 1
American Indian or Alaskan Native 1 1 1 3 1 0 0 1
Other 0 2 0 2 2 3 0 5
Latino/a (collected separately) 7 2 0 9 7 2 0 9
Education
Some high school or less 3 1 1 5 55 13 3 71
High school 41 9 3 53 90 22 10 122
Some college 94 20 15 129 72 9 10 91
College 133 21 19 173 97 15 17 129
Graduate school or professional training 144 20 28 192 100 12 25 137
Caregivers relationship to patient
Husband 57 8 6 71
Wife 198 21 46 265
Son 13 2 1 16
Daughter 147 40 13 200
Disease Stage
Earlier disease stages 267 48 37 352
Later disease Stage 148 23 29 200
Caregivers Patients






















Analysis of Covariance examining over all differences between caregivers on self report measures by diagnosis
df F p ηp
2 df F p ηp
2
Revised Memory and  Behavioral Problems Checklist
    Total Behavioral Problems Frequency 1,453 .01 .92 .001 1,451 .79 .37 .002
Frequency of Disruptive Behavioral Problems 1,465 1.17 .28 .003 1,460 .05 .83 .001
     Frequency of Depressive symptoms 1,470 5.20 .02* .01 1,465 .14 .71 .001
     Memory Problems Frequency 1,454 6.14 .01* .01 1,452 3.99 .05* .01
Zarit Burden Inventory 1,441 .43 .51 .001 1,436 .20 .66 .001
Marwit Meuser Caregiver Grief Inventory
Total Caregiver Grief 1,448 1.97 .16 .004 1,441 1.37 .24 .003
Personal Sacrifice Burden 1,448 .11 .74 .001 1,441 .19 .66 .001
Heartfelt Sadness & Longing 1,448 5.89 .02* .01 1,440 .15 .70 .001
Worry & Felt Isolation 1,448 .72 .40 .003 1,441 2.68 .10 .006
Note: * indicate significant difference (p  < .05); the covariates used were the caregiver’s relationship to the patient, the patient’s age, and the patient's sex                                   
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